162 related articles for article (PubMed ID: 27666017)
1. Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats.
Ikeda J; Kimoto N; Kitayama T; Kunori S
J Pharmacol Sci; 2016 Sep; 132(1):65-70. PubMed ID: 27666017
[TBL] [Abstract][Full Text] [Related]
2. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
[TBL] [Abstract][Full Text] [Related]
3. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
4. The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.
Uchii M; Sakai M; Hotta Y; Saeki S; Kimoto N; Hamaguchi A; Kitayama T; Kunori S
J Pharmacol Sci; 2017 Nov; 135(3):126-130. PubMed ID: 29113790
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
Brown SM; Smith CE; Meuth AI; Khan M; Aroor AR; Cleeton HM; Meininger GA; Sowers JR; DeMarco VG; Chandrasekar B; Nistala R; Bender SB
Endocrinology; 2017 Oct; 158(10):3592-3604. PubMed ID: 28977602
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α.
Connelly KA; Advani A; Zhang Y; Advani SL; Kabir G; Abadeh A; Desjardins JF; Mitchell M; Thai K; Gilbert RE
J Diabetes; 2016 Jan; 8(1):63-75. PubMed ID: 25565455
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
[TBL] [Abstract][Full Text] [Related]
9. Saxagliptin Prevents Increased Coronary Vascular Stiffness in Aortic-Banded Mini Swine.
Fleenor BS; Ouyang A; Olver TD; Hiemstra JA; Cobb MS; Minervini G; Emter CA
Hypertension; 2018 Aug; 72(2):466-475. PubMed ID: 29891647
[TBL] [Abstract][Full Text] [Related]
10. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
Yamaguchi T; Watanabe A; Tanaka M; Shiota M; Osada-Oka M; Sano S; Yoshiyama M; Miura K; Kitajima S; Matsunaga S; Tomita S; Iwao H; Izumi Y
J Pharmacol Sci; 2019 Feb; 139(2):112-119. PubMed ID: 30638989
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibition prevents cell death via extrinsic and intrinsic apoptotic pathways in rat pancreas with insulin resistance.
Nephan G; Coskun ZM; Bolkent S
Cell Biochem Funct; 2018 Jun; 36(4):212-220. PubMed ID: 29748970
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 independent cardiac dysfunction links saxagliptin to heart failure.
Koyani CN; Kolesnik E; Wölkart G; Shrestha N; Scheruebel S; Trummer C; Zorn-Pauly K; Hammer A; Lang P; Reicher H; Maechler H; Groschner K; Mayer B; Rainer PP; Sourij H; Sattler W; Malle E; Pelzmann B; von Lewinski D
Biochem Pharmacol; 2017 Dec; 145():64-80. PubMed ID: 28859968
[TBL] [Abstract][Full Text] [Related]
13. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
[TBL] [Abstract][Full Text] [Related]
14. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB.
Ma S; Bai Z; Wu H; Wang W
Eur J Pharmacol; 2019 May; 851():186-193. PubMed ID: 30639312
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
[TBL] [Abstract][Full Text] [Related]
16. The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway.
He L; Zhang T; Sun W; Qin Y; Wang Z; Dong W; Zhang H
Med Oncol; 2020 Oct; 37(11):97. PubMed ID: 33001278
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.
Connelly KA; Zhang Y; Advani A; Advani SL; Thai K; Yuen DA; Gilbert RE
Cardiovasc Ther; 2013 Oct; 31(5):259-67. PubMed ID: 22963483
[TBL] [Abstract][Full Text] [Related]
18. Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure.
Yin M; Silljé HH; Meissner M; van Gilst WH; de Boer RA
Cardiovasc Diabetol; 2011 Sep; 10():85. PubMed ID: 21955567
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
Liu YS; Huang ZW; Wang L; Liu XX; Wang YM; Zhang Y; Zhang M
J Pharmacol Sci; 2015 Mar; 127(3):260-74. PubMed ID: 25837922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]